Filtros de búsqueda

Lista de obras de Oliver W Press

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

artículo científico publicado en 2005

131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes

artículo científico publicado en 2012

90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution

artículo científico publicado en 2014

A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells

artículo científico publicado en 2014

A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab.

artículo científico publicado en 2013

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

artículo científico publicado en 2001

A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.

artículo científico publicado en 2006

A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.

artículo científico publicado en 2014

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911 ⬇️

artículo científico publicado el 8 de mayo de 2003

A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.

artículo científico publicado en 2013

A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas

scientific article published on 01 November 2000

A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.

artículo científico publicado en 2013

A pretargeted nanoparticle system for tumor cell labeling

artículo científico publicado en 2010

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

artículo científico publicado en 2006

A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

artículo científico publicado en 2015

A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.

artículo científico publicado en 2009

A roadmap for discovery and translation in lymphoma.

artículo científico publicado en 2015

A simplified microassay for inhibition of protein synthesis in reticulocyte lysates by immunotoxins

scientific article published on 01 November 1986

A streptavidin-biotin binding system that minimizes blocking by endogenous biotin.

artículo científico publicado en 2002

A technology platform to assess multiple cancer agents simultaneously within a patient's tumor

artículo científico publicado en 2015

Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older

artículo científico publicado en 2005

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

artículo científico publicado en 2008

Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins

scientific article published on 01 February 1996

Advances in the treatment of hematologic malignancies using immunoconjugates

scientific article published on 27 February 2014

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

artículo científico publicado en 2009

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience

artículo científico publicado en 1993

Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications

artículo científico publicado en 2017

Anti-CD22 Antibody Targeting of pH-responsive Micelles Enhances Small Interfering RNA Delivery and Gene Silencing in Lymphoma Cells ⬇️

artículo científico publicado el 31 de mayo de 2011

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.

artículo científico publicado en 2015

Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model

artículo científico publicado en 2011

Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model

artículo científico publicado en 2014

Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment

artículo científico publicado en 2015

Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice

artículo científico publicado en 2009

Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.

artículo científico publicado en 2008

Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies

scientific article published on 01 March 1998

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

artículo científico publicado en 2005

Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.

artículo científico publicado en 2015

Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

artículo científico publicado en 2001

Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

artículo científico publicado en 2016

Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model

artículo científico publicado en 2005

Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211

artículo científico publicado en 2009

Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.

artículo científico publicado en 2015

Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status

artículo científico publicado en 2014

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results ⬇️

artículo científico publicado el 3 de febrero de 2012

CD38 bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B cell malignancies.

artículo científico publicado en 2017

Characterization of HER2 status by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC).

artículo científico publicado en 2014

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

artículo científico publicado en 2015

Clinical applications of anti-CD20 antibodies.

artículo científico publicado en 1999

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

artículo científico publicado en 2017

Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma

artículo científico publicado en 2013

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma

artículo científico publicado en 2016

Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers

artículo científico publicado en 2016

Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models

artículo científico publicado en 2015

Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells

scientific article published on 01 May 1996

Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.

artículo científico publicado en 2002

Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.

artículo científico publicado en 2003

Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma

scientific article published on 01 December 2004

Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugates.

artículo científico publicado en 2003

Constitutive endocytosis and degradation of CD22 by human B cells

scientific article published on 01 May 1995

Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.

artículo científico publicado en 2010

Cutaneous T-cell lymphoma in sub-Saharan Africa

artículo científico publicado en 2013

Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain

artículo científico publicado el 1 de agosto de 1994

Depletion of Tregs for Adoptive T-cell Therapy Using CD44 and CD137 as Selection Markers ⬇️

artículo científico publicado el 1 de mayo de 2012

Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.

artículo científico publicado en 2010

Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation

artículo científico publicado en 1995

Differences in lifespan and rate of turnover between phytohaemagglutinin responsive cells of the bone marrow and of peripheral lymphoid organs ⬇️

artículo científico publicado el 1 de marzo de 1978

Diffuse Large B-Cell Lymphoma Version 1.2016

scientific article published on 01 February 2016

Drs Ramsey and Press Reply.

artículo científico publicado en 1984

Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease

scientific article published on 01 September 1988

Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium

artículo científico publicado en 2010

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.

artículo científico publicado en 2001

Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.

artículo científico publicado en 2014

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies

scientific article published on 01 September 1989

Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes

artículo científico publicado en 1988

Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides.

artículo científico publicado en 2017

Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.

artículo científico publicado en 2012

Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.

artículo científico publicado en 2007

Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies

artículo científico publicado en 2008

FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study

artículo científico publicado en 2016

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone ⬇️

artículo científico publicado el 22 de enero de 2012

Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial.

scientific article published on 07 July 2016

Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism.

artículo científico publicado en 2003

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

artículo científico publicado en 1998

Gemcitabine and Chlorotoxin Conjugated Iron Oxide Nanoparticles for Glioblastoma Therapy

artículo científico publicado en 2015

Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.

artículo científico publicado en 2010

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016

scientific article published on 16 November 2018

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

artículo científico publicado en 2015

Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.

artículo científico publicado en 2003

Hemolytic activity of pH-responsive polymer-streptavidin bioconjugates

artículo científico publicado en 1999

High dose radioimmunotherapy in malignant lymphoma

scientific article published on 01 January 1996

High dose radiolabeled antibody therapy of lymphoma

artículo científico publicado en 1990

High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.

artículo científico publicado en 2004

High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma

artículo científico publicado en 2015

High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.

artículo científico publicado en 2007

High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease

scientific article published on 01 November 1997

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

artículo científico publicado en 2002

High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.

artículo científico publicado en 2008

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy

scientific article published on 01 July 1993

High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells

scientific article published on 01 July 1996

High-dose radioimmunotherapy of B cell lymphomas

artículo científico publicado en 1990

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

artículo científico publicado en 2003

Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer

artículo científico publicado en 2015

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

artículo científico publicado en 2014

Imaging and treatment of B-cell lymphoma.

artículo científico publicado en 1990

Immunotherapy of Non-Hodgkin's lymphomas.

artículo científico publicado en 2001

Immunotoxins

scientific article published on 01 January 1991

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

artículo científico publicado en 2014

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma

artículo científico publicado en 2015

Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma

scientific article published on 01 October 1997

Improved conditioning regimens for autologous transplantation using targeted radiotherapy

artículo científico publicado en 2005

Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?

artículo científico publicado en 2013

Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy

artículo científico publicado en 2006

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model

artículo científico publicado en 2014

Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation

artículo científico publicado en 1999

Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.

artículo científico publicado en 2005

Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores.

artículo científico publicado en 1990

Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study

scientific article published on 01 March 1997

Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies

artículo científico publicado el 1 de diciembre de 1997

Intracellular catabolism of radiolabeled anti-CD3 antibodies by leukemic T cells ⬇️

artículo científico publicado el 1 de octubre de 1991

Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells.

artículo científico publicado en 1992

Intracellular delivery system for antibody-Peptide drug conjugates

artículo científico publicado en 2015

Is there a better way to deliver total body irradiation?

artículo científico publicado el 1 de enero de 1992

Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model ⬇️

artículo científico publicado el 1 de enero de 1992

Localized beta dosimetry of 131 I ‐labeled antibodies in follicular lymphoma ⬇️

artículo científico publicado el 1 de enero de 1992

Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma

scientific article published on 03 July 2018

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation

artículo científico publicado en 2014

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies

artículo científico publicado en 2015

Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.

artículo científico publicado en 2013

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma

artículo científico publicado en 2015

Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation ⬇️

artículo científico publicado el 5 de julio de 2011

Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop

artículo científico publicado en 2010

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop

artículo científico publicado en 2010

Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulation

artículo científico publicado en 2010

Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy

artículo científico

Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.

artículo científico publicado en 2016

Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation

artículo científico publicado en 1998

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

artículo científico publicado en 1987

Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose

scientific article published on 15 April 2008

Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma

artículo científico publicado en 2014

Myeloablative Radiolabeled Antibody Therapy with Autologous Bone marrow Transplantation for Relapsed B Cell Lymphomas ⬇️

artículo científico publicado el 1 de enero de 1995

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

artículo científico publicado en 2010

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

artículo científico publicado en 2017

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

artículo científico publicado en 2016

Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies

scientific article published on 01 October 1998

Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells

artículo científico publicado en 2000

Non-FcR-binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo

artículo científico publicado en 2000

Non-Hodgkin's Lymphomas, version 3.2012

artículo científico publicado en 2012

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology

artículo científico publicado en 2006

Non-Hodgkin's lymphomas

artículo científico publicado en 2008

Non-Hodgkin's lymphomas

artículo científico publicado en 2011

Non-Hodgkin's lymphomas, version 1.2013.

artículo científico publicado en 2013

Non-Hodgkin's lymphomas, version 2.2014

artículo científico publicado en 2014

Non-Hodgkin's lymphomas, version 4.2014.

artículo científico publicado en 2014

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

artículo científico publicado en 2016

Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains

artículo científico publicado en 2007

Pancytopenia in mannosidosis

artículo científico publicado en 1983

Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy

artículo científico publicado en 2017

Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome

artículo científico publicado en 1999

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

artículo científico publicado en 1995

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.

artículo científico publicado en 2006

Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246 ⬇️

artículo científico publicado el 1 de febrero de 1998

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016.

artículo científico publicado en 2012

Phytohemagglutinin-induced differentiation and blastogenesis of precursor T cells from mouse bone marrow ⬇️

artículo científico publicado en 1977

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

artículo científico publicado en 2001

Post therapy imaging in high dose I-131 radioimmunotherapy patients

artículo científico publicado en 1994

Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions.

artículo científico publicado en 2017

Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab.

artículo científico publicado en 2016

Pretargeted radioimmunotherapy for hematologic and other malignancies

artículo científico publicado en 2010

Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.

artículo científico publicado en 2009

Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma

artículo científico publicado en 2011

Pretargeting with bispecific fusion proteins facilitates delivery of nanoparticles to tumor cells with distinct surface antigens

artículo científico publicado en 2017

Principles of radioimmunotherapy for hematologists and oncologists.

artículo científico publicado en 2000

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.

artículo científico publicado en 2009

Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.

artículo científico publicado en 1998

Pseudotumor cerebri and hypothyroidism

artículo científico publicado en 1983

Qualitative differences in the lymphocyte phytohemagglutinin (PHA) response between the bone marrow and other lymphoid organs

artículo científico publicado en 1977

Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera

artículo científico publicado en 2015

R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433.

artículo científico publicado en 2014

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma.

artículo científico publicado en 2011

Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission

artículo científico publicado en 2015

Radioimmunotherapy for non-Hodgkin's lymphomas: a historical perspective.

artículo científico publicado en 2003

Radioimmunotherapy of human tumours

artículo científico publicado en 2015

Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome

artículo científico publicado en 2014

Radiolabeled antibody targeting of the HER-2/neu oncoprotein ⬇️

artículo científico publicado el 1 de abril de 1992

Radiolabeled antibody therapy of human B cell lymphomas

scientific article published on 01 January 1991

Radiolabeled antibody therapy of lymphoma.

artículo científico publicado en 1993

Radiolabeled antibody therapy of lymphomas.

artículo científico publicado en 1995

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support ⬇️

artículo científico publicado el 21 de octubre de 1993

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

artículo científico publicado en 2015

Reply to H.J.A. Adams et al and E.A. Hawkes et al

artículo científico publicado en 2016

Reply to “Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story?” Haematologica. 2012;97(11):e45.

artículo científico publicado en 2012

Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma

artículo científico publicado en 2017

Retention of B-cell-specific monoclonal antibodies by human lymphoma cells

scientific article published on 01 March 1994

Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.

artículo científico publicado en 1988

Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use.

artículo científico publicado en 2013

Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.

artículo científico publicado en 2008

Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.

artículo científico publicado en 2005

Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.

artículo científico publicado en 2015

Selection of first-line therapy for advanced follicular lymphoma

artículo científico publicado en 2013

Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.

artículo científico publicado en 2016

Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells

artículo científico publicado en 2000

Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission

artículo científico publicado en 2011

Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy

artículo científico publicado en 2015

Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.

artículo científico publicado en 2002

Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.

artículo científico publicado en 2001

T-cell immunotherapy: looking forward

artículo científico publicado en 2014

Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate

scientific article published on 29 May 2007

Targeted therapy for hematologic malignancies: has its promise been realized?

artículo científico publicado en 1995

Temozolomide nanoparticles for targeted glioblastoma therapy

artículo científico publicado en 2015

The differentiation of B and T lymphocytes from precursor cells resident in the bone marrow

artículo científico publicado el 1 de enero de 1978

The distribution of rapidly and slowly renewed T, B, and “null” lymphocytes in mouse bone marrow, thymus, lymph nodes, and spleen ⬇️

artículo científico publicado el 1 de septiembre de 1977

The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.

artículo científico publicado en 2007

The potential for immunoconjugates in lymphoma therapy.

artículo científico publicado en 1997

The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation

artículo científico publicado en 2007

The relative importance of the bone marrow and spleen in the production and dissemination of B lymphocytes ⬇️

artículo científico publicado el 1 de abril de 1978

The role of radioimmunotherapy in bone marrow transplantation ⬇️

artículo científico publicado el 1 de noviembre de 1996

The use of radioimmunoconjugates in stem cell transplantation.

artículo científico publicado en 2002

The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia

artículo científico publicado en 1992

The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies.

artículo científico publicado en 1997

Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience.

artículo científico publicado en 2000

Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma

artículo científico publicado en 2017

Translocation of ricin A-chain into proteoliposomes reconstituted from Golgi and endoplasmic reticulum.

artículo científico publicado en 1995

Treatment of lymphoma with adoptively transferred T cells.

artículo científico publicado en 2009

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

artículo científico publicado en 1989

Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation

artículo científico publicado en 1991

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

scientific article published on 11 April 2016

Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas

artículo científico publicado en 2017

Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents.

artículo científico publicado en 2015

Whither Radioimmunotherapy: To Be or Not To Be?

artículo científico publicado en 2017

Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia

scientific article published on 03 October 2019

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

artículo científico publicado en 2018

α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation

artículo científico publicado en 2015

⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma

artículo científico publicado en 2011

Inmunoterapias emergentes para linfomas no Hodgkin: la tortuga se acerca a la línea de meta

artículo científico publicado en 2000

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda